Astellas Pharma (($ALPMY)) announced an update on their ongoing clinical study. Study Overview: Astellas Pharma is ...

View today's Astellas Pharma Inc. stock price and latest 4503 news and analysis. Create real-time notifications to follow any changes in the live stock price.

Astellas Pharma has agreed its largest-ever acquisition, buying US biotech Iveric Bio in a deal that continues to build its presence in the ophthalmology sector, The $40-per-share offer values ...

Get the detailed quarterly/annual income statement for Astellas Pharma Inc. (ALPMY). Find out the revenue, expenses and profit or loss over the last fiscal year.

Marci English, head of biopharma and ophthalmology development at Astellas Pharma, said the FDA's change of heart will "further [solidify] Izervay's status as a trusted choice for thousands of GA ...

Vernal keratoconjunctivitis (VKC) is a chronic allergic eye disease that, if untreated, can cause severe ocular complications. Characterized by itching, redness, and swelling, VKC is receiving ...

Astellas Pharma FY Oper Pft Y41.04B Vs Pft Y25.52B. Apr. 25, 2025 at 2:30 a.m. ET. Biotech and Pharma Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment ...